Evidence map›Paper›PMID 35909518›Full record

ArticleFrontiers in endocrinology2022

Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy

Mingfei Guo, Yaji Dai, Lei Jiang, Jiarong Gao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Mechanism of transforming growth factor-Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2023
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Mingfei GuoDepartment of Pharmacy, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, China.
Yaji DaiDepartment of Pharmacy, Anhui No.2 Provincial People's Hospital, Hefei, China.
Lei JiangDepartment of Pharmacy, Anhui No.2 Provincial People's Hospital, Hefei, China.
Jiarong GaoDepartment of Pharmacy, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Anhui Provincial Hospital · CNAnhui University of Traditional Chinese Medicine · CNFourth Affiliated Hospital of Anhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic nephropathy (DN) is one of the common chronic complications of diabetes with unclear molecular mechanisms, which is associated with end-stage renal disease (ESRD) and chronic kidney disease (CKD). Our study intended to construct a competing endogenous RNA (ceRNA) network

Indexed as

Diabetes MellitusDiabetic NephropathiesMicroRNAsRNA, Long NoncodingBiomarkersComputational BiologyGene Regulatory NetworksHumansPhosphatidylinositol 3-KinasesRNA, MessengerBiomarkersMicroRNAsMIRN326 microRNA, humanMIRN577 microRNA, humanMIRN944 microRNA, humanPhosphatidylinositol 3-KinasesRNA, Long NoncodingRNA, Messengerbioinformatics analysisbiomarkersceRNAdiabetic neuropathymechanisms

Identifiers

PMID35909518
PMCPMC9329782
OpenAlexW4285386548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.